Bacterial Pneumonia: Clinical Trials

3 trials for Bacterial Pneumonia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3
Phase 11Completed 1

Follow Bacterial Pneumonia: new trials by email Literature Review of Bacterial Pneumonia trials Research Report on Bacterial Pneumonia

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cx611-0204 SEPCELL Study
Cx611, Placebo - Bacterial Pneumonia
Phase 1 / Phase 2CompletedTigenix S.A.U.842017-01-302022-04-06
An Effectiveness, Safety, and Microbiology Study of Doripenem in Patients With Nosocomial (Hospital-acquired) Pneumonia
doripenem - Pneumonia, Bacterial Pneumonia
Phase 2CompletedPriCara, Unit of Ortho-McNeil, Inc.1852007-08-012013-09-25
Ertapenem Study in Pediatric Patients Who Have Urinary Tract Infections, Skin Infections or Community-acquired Pneumonia (0826-036)
MK0826, ertapenem sodium /Duration of Treatment: 14 Days, Comparator: ceftriaxone sodium /Duration of Treatment: 14 Days - Urinary Tract Infections, Bacterial Pneumonia
Phase 2CompletedMerck Sharp & Dohme LLC4002002-01-012017-02-17

Narrower conditions

Pneumonia, Bacterial (3)  ·  Bacterial Infections (1)  ·  Cross Infection (1)  ·  Pneumonia (1)  ·  Pneumonia, Ventilator-Associated (1)  ·  Soft Tissue Infections (1)  ·  Urinary Tract Infections (1)

Broader conditions

Bacterial Infections and Mycoses (3)  ·  Infections (3)  ·  Lung Diseases (3)  ·  Respiratory Tract Diseases (3)  ·  Respiratory Tract Infections (3)  ·  Bacterial Infections (2)  ·  Pneumonia (2)  ·  Disease Attributes (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Healthcare-Associated Pneumonia (1)  ·  Iatrogenic Disease (1)  ·  Male Urogenital Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Doripenem (1)  ·  Duration of Therapy (1)  ·  Ertapenem (1)

Sponsors

Merck Sharp & Dohme LLC (1)  ·  PriCara, Unit of Ortho-McNeil, Inc. (1)  ·  Tigenix S.A.U. (1)

Countries

France (2)  ·  Argentina (1)  ·  Belgium (1)  ·  Canada (1)  ·  Chile (1)  ·  Croatia (1)  ·  India (1)  ·  Italy (1)  ·  Lithuania (1)  ·  Norway (1)  ·  Russia (1)  ·  Spain (1)  ·  Ukraine (1)  ·  United States (1)

Results publications

PMID 33238991, PMID 37918129

NIH funding

2015 (1)